Astera Labs, Inc. $ALAB Shares Acquired by Hoey Investments Inc.

Key Points

• Hoey Investments Inc. increased its holdings in Astera Labs by 22.4% during the 2nd quarter, acquiring an additional 1,121 shares worth approximately $553,000.
• Astera Labs reported $0.44 earnings per share for the last quarter, exceeding analysts' expectations of $0.33 and marking a 149.5% year-over-year revenue growth.
• Several analysts have upgraded Astera Labs' ratings, with a consensus price target of $152.94 and 15 analysts giving a Buy rating, reflecting a generally positive outlook for the stock.

Hoey Investments Inc. boosted its position in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 22.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,121 shares of the company's stock after acquiring an additional 1,121 shares during the quarter. Hoey Investments Inc.'s holdings in Astera Labs were worth $553,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs in the 2nd quarter valued at approximately $29,000. GAMMA Investing LLC grew its stake in shares of Astera Labs by 55.7% during the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after purchasing an additional 284 shares in the last quarter. Sound Income Strategies LLC grew its stake in shares of Astera Labs by 34.7% during the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after purchasing an additional 204 shares in the last quarter. Harbour Investments Inc. increased its holdings in Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock valued at $47,000 after buying an additional 619 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. acquired a new stake in Astera Labs in the first quarter valued at $48,000. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Stock Performance

ALAB stock opened at $237.30 on Tuesday. The stock has a market capitalization of $39.44 billion, a PE ratio of 423.75, a price-to-earnings-growth ratio of 6.22 and a beta of 1.46. The company has a fifty day moving average of $172.89 and a 200-day moving average of $111.31. Astera Labs, Inc. has a one year low of $47.13 and a one year high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.33 by $0.11. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. During the same period in the prior year, the company posted $0.13 earnings per share. The firm's revenue for the quarter was up 149.5% on a year-over-year basis. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Equities analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ALAB shares. Susquehanna upped their price objective on Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a research report on Thursday, August 7th. CICC Research began coverage on Astera Labs in a report on Friday, August 29th. They issued an "outperform" rating and a $190.00 price target for the company. Northland Capmk lowered shares of Astera Labs from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, July 22nd. Zacks Research upgraded shares of Astera Labs to a "strong-buy" rating in a research report on Tuesday, August 12th. Finally, Northland Securities downgraded shares of Astera Labs from an "outperform" rating to a "market perform" rating and set a $120.00 target price on the stock. in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and three have issued a Hold rating to the company's stock. According to MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and an average price target of $152.94.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 91,441 shares of the firm's stock in a transaction on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares of the company's stock, valued at approximately $398,377,638.27. This trade represents a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, General Counsel Philip Mazzara sold 10,000 shares of the business's stock in a transaction on Thursday, August 28th. The stock was sold at an average price of $188.70, for a total transaction of $1,887,000.00. Following the sale, the general counsel owned 161,573 shares in the company, valued at $30,488,825.10. The trade was a 5.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,576,027 shares of company stock worth $239,177,011. Corporate insiders own 12.50% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.